公告显示，11月25日，*ST苏吴收到中国证监会下发的《行政处罚决定书》，认定公司未如实披露实际 控制人，2018年至2023年年度报告存在虚假记载；虚增营业收入、营业成本和利润，未按规定披露关联 方非经营性占用资金情况，2020年至2023年年度报告存在虚假记载和重大遗漏。上述情形触及《股票上 市规则》规定的重大违法强制退市情形，公司股票将被实施重大违法强制退市。 北京商报讯(记者丁宁)11月25日晚间，*ST苏吴（600200）发布公告称，公司股票将被实施重大违法强 制退市，依据《上海证券交易所股票上市规则》(以下简称"《股票上市规则》")第9.5.7条相关规定，公 司股票自11月26日起停牌。 ...

Core Insights - The average stock price of A-shares is 13.48 yuan, with 25 stocks priced below 2 yuan, the lowest being *ST Yuan Cheng at 0.58 yuan [1] - Among the low-priced stocks, 8 are ST stocks, accounting for 32% of the total [1] - In terms of market performance, 15 of the low-priced stocks increased in price, with *ST Su Wu leading at a 5.08% rise [1] Low-Priced Stocks Overview - The lowest priced stock is *ST Yuan Cheng at 0.58 yuan, followed by *ST Su Wu at 1.24 yuan and Chongqing Steel at 1.43 yuan [1] - The daily performance of low-priced stocks shows that *ST Su Wu, ST Lingnan, and Rongsheng Development had the highest increases, while Chongqing Steel, Shandong Steel, and Liaogang shares experienced declines [1] - The table of low-priced stocks includes various sectors such as construction decoration, pharmaceuticals, steel, real estate, and transportation [1][2]

Core Insights - Suzhou Times New Energy Technology Co., Ltd. (referred to as "Times New Energy") has launched a new generation of pure electric light truck "Kunpeng ET9" in collaboration with Jianghuai 1 Card, featuring the innovative "Kunshi" zero-carbon technology architecture [1] - The Kunpeng ET9 integrates a customized Tianxing battery, a high-efficiency flat wire oil-cooled motor, and the BrainOne central domain control system, achieving over 25% reduction in comprehensive energy consumption and saving users more than 20,000 yuan annually [1] - This launch marks the first commercial application of the highly efficient integrated system from CATL in the commercial vehicle sector, indicating a significant advancement in the integration of battery, motor, and electronic control systems [1] Company Overview - Times New Energy, an innovative incubation enterprise under CATL, focuses on the electrification and integration innovation of commercial vehicles, covering core component R&D, three-electric system integration, and intelligent chassis solutions [1] - The company has established a project in Jiangsu Wuzhong District with a total investment of 5 billion yuan, occupying 128 acres, and aims to achieve an annual production capacity of 50,000 sets of power domain control systems and 100,000 sets of automotive chassis components, with projected annual sales revenue of 10 billion yuan upon full production [1] Industry Context - The "1+3+1" architecture of the Kunshi chassis commercial vehicle ecosystem solution addresses the urgent demand for "high efficiency, low energy consumption, and high reliability" in the domestic new energy commercial vehicle market [2] - The solution has passed multiple professional performance tests at national-level testing grounds in Chongqing and Xiangyang, with products based on this solution receiving high recognition from well-known logistics companies [2] - Wuzhong District is focusing on cultivating the "new energy + smart vehicle" industry as a core industry, steadily progressing towards a trillion-level industry scale, with several companies achieving breakthroughs in key technologies [2]

New Stock Issuance - The new stock issuance for Moer Thread (证券代码: 787795) is priced at 114.28 RMB per share, effective from November 24, 2025[1] - Tianpu Co., Ltd. (证券代码: 605255) is undergoing a tender offer period from November 20 to December 19, 2025[1] Cash Options - Hangzhou Qilun B (证券代码: 200771) has a cash option declaration period from November 19 to November 25, 2025[1] Market Alerts - Jiumuwang (证券代码: 601566) has reported severe abnormal fluctuations[1] - Hefu China (证券代码: 603122) is also noted for significant abnormal fluctuations[1] Recent Announcements - Huasheng Lithium Battery (证券代码: 688353) and Pinming Technology (证券代码: 688109) have recent announcements regarding their stock activities[1] - ST Yuan Cheng (证券代码: 603388) and ST Keli Da (证券代码: 603828) have also made recent disclosures[1] Trading Updates - The trading updates include various companies with links to their respective announcements, indicating ongoing market activities and potential investment opportunities[1]

一、公司存在重大违法退市风险 证券代码：600200 证券简称：*ST苏吴 公告编号：临2025-136 江苏吴中医药发展股份有限公司 关于股票交易暨退市风险提示公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要风险提示： 江苏吴中医药发展股份有限公司(以下简称"公司") 股票价格近四日连 续涨停，最近四个交易日公司股票价格涨幅达到 21.65%，可能存在市场情绪过 热及非理性炒作迹象，积累了较大交易风险。公司股票目前存在重大违法强制退 市、财务类退市、面值退市等多重退市风险，投资者在买入本公司股票前，应当 认真阅读本公告及公司已披露的其他信息，充分了解股票可能被终止上市的风 险，买入本公司股票的投资者将承担公司股票可能被终止上市的全部风险，包 括但不限于投资损失无法获得赔偿，请投资者审慎做出投资决策。 公司因涉嫌信息披露违法违规，被中国证券监督管理委员会（以下简称 "中国证监会"）立案调查。2025 年 7 月 13 日，公司收到中国证监会下发的《行 政处罚事先告知书》（处罚字〔2025〕58 号）。认定公司虚增营业 ...

人民财讯11月24日电，*ST苏吴（600200）11月24日公告，公司股票价格近四日连续涨停，最近四个交 易日公司股票价格涨幅达到21.65%，可能存在市场情绪过热及非理性炒作迹象，积累了较大交易风 险。公司股票目前存在重大违法强制退市、财务类退市、面值退市等多重退市风险，投资者在买入公司 股票前，应当认真阅读本公告及公司已披露的其他信息，充分了解股票可能被终止上市的风险，买入公 司股票的投资者将承担公司股票可能被终止上市的全部风险，包括但不限于投资损失无法获得赔偿，请 投资者审慎做出投资决策。 ...

证券代码：600200 证券简称：*ST苏吴 公告编号：临2025-135 江苏吴中医药发展股份有限公司 股票交易异常波动的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要风险提示： 江苏吴中医药发展股份有限公司（以下简称"公司"）股票于 2025 年 11 月 19 日、2025 年 11 月 20 日、2025 年 11 月 21 日连续三个交易日内收盘价 格涨幅偏离值累计超过 12%，根据《上海证券交易所交易规则》的有关规定，属 于股票交易异常波动的情形。 江苏吴中医药发展股份有限公司(以下简称"公司")因涉嫌信息披露违 法违规，被中国证券监督管理委员会（以下简称"中国证监会"）立案调查。2025 年 7 月 13 日，公司收到中国证监会下发的《行政处罚事先告知书》（处罚字〔2025〕 58 号）。认定公司虚增营业收入、营业成本和利润，2020 年至 2023 年年度报告 存在虚假记载，触及重大违法强制退市情形。公司股票已于 2025 年 7 月 14 日起 被叠加实施重大违法类强制退市风险警示。 如根据正式的 ...

Core Viewpoint - Aimeike, once a leading player in the medical beauty industry, is facing significant challenges with declining performance and ongoing disputes over product agency rights, prompting a recent board reshuffle to address these issues [1][2][6]. Company Overview - Aimeike's actual controller, Jian Jun, was re-elected as chairman, while the management team remains stable, with Li Dongmei being promoted to a key role amid the company's current challenges [1][2]. - The company has seen a drastic decline in stock price and market capitalization, dropping from a peak of over 150 billion yuan to around 45 billion yuan [2][6]. Financial Performance - In the first half of 2025, Aimeike reported a revenue of 5.66 billion yuan and a net profit of 3.04 billion yuan, marking declines of 21.27% and 34.61% year-on-year, respectively [2][6]. - The company experienced its first negative growth in 2025, with revenue and net profit both declining over 20% [6][7]. Product Development and Market Position - Aimeike's growth has been closely tied to its innovative product development, with key products like "HiTi" and "Luhua Tianzi" driving significant revenue [3][5]. - The company has expanded its product matrix, with "HiTi" achieving a revenue share increase from 15.34% in 2017 to 43.5% in 2019 [4]. Competitive Landscape - The medical beauty industry is undergoing rapid changes, with increased competition leading to a dilution of Aimeike's product advantages, particularly for "HiTi" and "Luhua Tianzi" [7][8]. - New entrants in the market have intensified competition, with the number of approved "童颜针" products increasing to seven, further squeezing Aimeike's growth potential [8][9]. Strategic Initiatives - Aimeike is diversifying its product offerings, including the launch of new products like "Kela" and expanding into biopharmaceuticals and chemical drugs [9][10]. - The company has also pursued acquisitions, such as the purchase of a majority stake in REGEN, to enhance its product portfolio and market competitiveness [10][11]. Legal and Regulatory Challenges - Aimeike is embroiled in a significant dispute over the agency rights for its product "AestheFill," which could impact its market performance and brand partnerships [11][12]. - The ongoing arbitration with Jiangsu Wuzhong over the exclusive distribution rights of "AestheFill" highlights the complexities of brand ownership and distribution in the medical beauty sector [12][15].

证券代码：600200 证券简称：*ST 苏吴 公告编号：临 2025-134 本公司董事会及董事会全体成员保证公告内容不存在虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实、准确和完整承担法律责任。 重要风险提示： 江苏吴中医药发展股份有限公司(以下简称"公司")因涉嫌信息披露违 法违规，被中国证券监督管理委员会（以下简称"中国证监会"）立案 调查。2025 年 7 月 13 日，公司收到中国证监会下发的《行政处罚事先 告知书》（处罚字〔2025〕58 号）。认定公司虚增营业收入、营业成本 和利润，2020 年至 2023 年年度报告存在虚假记载，触及重大违法强制 退市情形。公司股票已于 2025 年 7 月 14 日起被叠加实施重大违法类强 制退市风险警示。 如根据正式的处罚决定书结论，公司触及重大违法强制退市情形，公司 股票将被终止上市。根据《上海证券交易所股票上市规则》，如公司后 续收到行政处罚决定书，认定公司触及重大违法类强制退市情形，公司 将申请停牌，并及时披露有关内容；复牌后，公司股票进入退市整理期。 退市整理期届满后 5 个交易日内，上海证券交易所对上市公司股票予以 摘牌，公司股票终止上市 ...

Core Points - The average stock price of A-shares is 13.67 yuan, with 22 stocks priced below 2 yuan, the lowest being *ST Yuan Cheng at 0.58 yuan [1] - Among the low-priced stocks, 8 are ST stocks, accounting for 36.36% of the total [1] - The Shanghai Composite Index closed at 3931.05 points as of November 20 [1] Low-Priced Stocks Summary - The lowest priced stock is *ST Yuan Cheng at 0.58 yuan, with a market sector of construction decoration [1] - *ST Su Wu and *ST Jin Ke follow with closing prices of 1.07 yuan and 1.48 yuan, respectively, in the pharmaceutical and real estate sectors [1] - Among the low-priced stocks, 6 increased in price today, with *ST Su Wu leading at a 4.90% increase [1] Market Performance - 10 low-priced stocks experienced declines, with ST Yi Gou and *ST Hui Feng showing the largest drops at 2.21% and 2.17%, respectively [1] - The trading volume for *ST Su Wu was notable with a turnover rate of 10.86% [1] - The price-to-book ratio for *ST Yuan Cheng is 0.27, indicating a low valuation compared to its book value [1]